JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3501
Veritone
VERI
$75.9M
| $1.37M | ﹤0.01% |
171,897
+169,826
| +8,200% | +$1.26M |
2017 Q4
6 quarters
|
|
|
SAFE
3502
DELISTED
Safehold Inc.
SAFE
| $1.37M | ﹤0.01% |
47,146
+23,157
| +97% | +$615K |
2017 Q4
6 quarters
|
|
3503
Range Resources
RRC
$9.35B
| $1.37M | ﹤0.01% |
198,264
-2,006
| -1% | -$17.4K |
2013 Q2
24 quarters
|
|
3504
Akebia Therapeutics
AKBA
$243M
| $1.36M | ﹤0.01% |
294,813
+14,869
| +5% | +$84.6K |
2017 Q4
6 quarters
|
|
3505
CALL
Cheniere Energy
LNG
$56.9B
| $1.36M | ﹤0.01% |
+20,000
| New | +$1.32M |
2019 Q2
0 quarters
|
|
|
3506
PUT
Cheniere Energy
LNG
$56.9B
| $1.36M | ﹤0.01% |
+20,000
| New | +$1.32M |
2019 Q2
0 quarters
|
|
|
LX
3507
LexinFintech Holdings
LX
$114M
| $1.36M | ﹤0.01% |
+117,246
| New | +$1.46M |
2019 Q2
0 quarters
|
|
|
WBA
3508
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $1.36M | ﹤0.01% |
25,000
| – | – |
2014 Q3
19 quarters
|
|
3509
CALL
Tyson Foods
TSN
$18.3B
| $1.36M | ﹤0.01% |
17,100
-1,019,600
| -98% | -$78.5M |
2017 Q3
7 quarters
|
|
3510
VanEck High Yield Muni ETF
HYD
$3.91B
| $1.36M | ﹤0.01% |
21,346
+4,043
| +23% | +$255K |
2015 Q4
14 quarters
|
|
3511
Sierra Bancorp
BSRR
$512M
| $1.36M | ﹤0.01% |
51,942
-9,145
| -15% | -$235K |
2013 Q2
24 quarters
|
|
3512
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$569M
| $1.36M | ﹤0.01% |
44,552
-653
| -1% | -$19.7K |
2014 Q4
18 quarters
|
|
3513
3D Systems Corp
DDD
$596M
| $1.35M | ﹤0.01% |
153,500
+117,665
| +328% | +$1.11M |
2015 Q4
14 quarters
|
|
3514
CytomX Therapeutics
CTMX
$558M
| $1.35M | ﹤0.01% |
127,293
-7,166
| -5% | -$75.1K |
2016 Q4
10 quarters
|
|
|
BBBY
3515
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.35M | ﹤0.01% |
117,454
-826,343
| -88% | -$12.3M |
2013 Q2
24 quarters
|
|
3516
Inseego
INSG
$83.2M
| $1.34M | ﹤0.01% |
30,962
-16,914
| -35% | -$796K |
2016 Q4
10 quarters
|
|
3517
QuinStreet
QNST
$859M
| $1.34M | ﹤0.01% |
84,527
-3,475
| -4% | -$51.9K |
2016 Q3
11 quarters
|
|
3518
Werner Enterprises
WERN
$1.97B
| $1.33M | ﹤0.01% |
43,281
+3,949
| +10% | +$127K |
2014 Q4
18 quarters
|
|
3519
Citizens & Northern Corp
CZNC
$456M
| $1.33M | ﹤0.01% |
52,419
-249
| -0.5% | -$6.79K |
2013 Q2
24 quarters
|
|
|
BRSP
3520
BrightSpire Capital
BRSP
$480M
| $1.33M | ﹤0.01% |
86,842
+66,437
| +326% | +$1.04M |
2018 Q2
4 quarters
|
|
3521
OrthoPediatrics
KIDS
$593M
| $1.33M | ﹤0.01% |
34,418
+465
| +1% | +$18.7K |
2017 Q4
6 quarters
|
|
3522
IMAX
IMAX
$2.77B
| $1.32M | ﹤0.01% |
68,867
+45,166
| +191% | +$1.02M |
2014 Q2
20 quarters
|
|
3523
First Trust Technology AlphaDEX Fund
FXL
$2.94B
| $1.32M | ﹤0.01% |
19,879
+69
| +0.3% | +$4.51K |
2017 Q4
6 quarters
|
|
3524
Zoom
ZM
$27.5B
| $1.32M | ﹤0.01% |
+14,580
| New | +$1.2M |
2019 Q2
0 quarters
|
|
|
RAVN
3525
DELISTED
Raven Industries Inc
RAVN
| $1.31M | ﹤0.01% |
37,586
+1,490
| +4% | +$54.6K |
2016 Q3
11 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.